Neurology

Updated Contraindications, Dosing for Gaucher Disease Treatment Cerdelga

Cerdelga is indicated for the long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers, intermediate metabolizers, or poor metabolizers as detected by an FDA-cleared test.

Source link

Related posts

Cannabis for Chronic Nerve Pain: Mechanism Revealed?

Newsemia

Post-GWAS knowledge gap: the how, where, and when

Newsemia

What is so distinctive about anti-MUSK myasthenia gravis?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World